Ultralife Corporation Common Stock (ULBI)

FairStock Score: 45/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for businesses that earn decent returns on capital and can be bought at a discount to conservatively estimated value. Ultralife is a small industrial power and communications company with 678 employees and two segments. The record is uneven. In fiscal Q2 2026, the quarter ended 2026-06-30, it reported revenue of $47.9M and net income of $2.5M. In fiscal Q1 2026, the quarter ended 2026-03-31, revenue was $47.4M and net income was -$451,000. For full-year fiscal 2025, ended 2025-12-31, revenue was $191.2M and net income was -$5.9M, after fiscal 2024 net income of $6.3M. FairStock classifies it as TURNAROUND—loss in the latest year after earlier profits. At the 2026-10-26 close of $6.01, FairStock calculates P/B of 0.77, P/E of -15.41, ROE of -4.91%, ROCE of 2.10%, FCF yield of 2.0%, and a FairStock Score of 45/100. The price-to-book discount may offer a margin of safety if earnings normalize, and a Piotroski F-Score of 7/9 suggests some improvement. But Altman Z-Score of 1.14 is weak, free cash flow of $2.0M is thin, and the company has not shown durable profitability. I see no wide moat in this competitive battery and communications niche; the latest positive quarter is encouraging but not enough. I would need several quarters of consistent profits and better returns on capital before calling this a sound value.

In plain English: Ultralife makes batteries and power and communication systems for customers worldwide. The business looks mixed: it lost money in fiscal 2025 but had a profitable latest quarter, and cash generation is thin. At $6.01, the price looks low compared with the accounting value of its net assets, but profits are not yet consistently strong.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-26 close · note generated 2026-10-28 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer